
Why Trump’s Obesity Drug ‘Deal’ Will Help Big Pharma Most Of All
With the market for GLP-1s already exploding, Americans might be best served by a government that focuses on promoting competition to drive down prices.
You may also like
By mfnnews
search
categories
Archives
navigation
Recent posts
- Former New Jersey Governor Who Took Over For Scandal-Plagued Predecessor Dies January 11, 2026
- Philadelphia Sheriff Goes Viral For Threatening ICE January 11, 2026
- The Obamacare subsidy fight exposes who Washington really serves January 11, 2026
- The crisis of ‘trembling pastors’: Why church leaders are ignoring core theology because it’s ‘political’ January 11, 2026
- Dobol B TV Livestream: January 12, 2026 January 11, 2026
- Ogie Diaz ukol kay Liza Soberano: ‘Wala siyang sama ng loob sa akin. Ako rin naman…’ January 11, 2026
- LOOK: Another ‘uson” descends Mayon Volcano January 11, 2026








Leave a Reply
You must be logged in to post a comment.